Ridgetech Inc.(RDGT)Earnings, Financials & Key Ratios
RDGT•NASDAQ
$1.33
Price updated Jul 7, 2026
AboutRidgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.Show more
- Revenue$120M-22.4%
- EBITDA$5M+169.2%
- Net Income$10M+340.8%
- EPS (Diluted)41400.00+162.8%
- Gross Margin3.2%-84.1%
- EBITDA Margin4.15%+246.8%
- Operating Margin-0.86%+62.3%
- Net Margin8.5%+410.1%
- ROE46.41%+269.7%
RDGT Price & Volume
Ridgetech Inc. (RDGT) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Contraction Signals Structural Business Decline
Investment Thesis • Updated 2026Q2
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Deteriorating
Primary Risk:Regulatory-driven business model collapse
Key Thesis Takeaways
- Ridgetech Inc.
- faces a precarious outlook as it navigates a 22.37% year-over-year revenue decline and persistent margin compression within the Chinese medical distribution sector.
- The company's operational viability appears increasingly strained, evidenced by a shift toward a razor-thin 3.2% gross margin and the near-total divestment of its physical infrastructure, with net PPE falling to $7.1K.
- Investors should monitor the sustainability of the current business model, as the reliance on non-operating items to mask underlying operating deficits suggests significant long-term risk.
Verdict Logic
the company's fundamental health is undermined by persistent operating losses and a 22.37% year-over-year revenue decline, suggesting that current cash reserves of $13.9M may be insufficient to support long-term operations.
RDGT Growth Metrics
Ridgetech Inc. (RDGT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years4.55%
5 Years0.45%
3 Years-9.97%
TTM-17.41%
Profit CAGR
10 Years28.1%
5 Years-
3 Years-
TTM127.31%
EPS CAGR
10 Years-18.6%
5 Years-
3 Years-
TTM99.72%
Return on Capital
10 Years-25.49%
5 Years-24.5%
3 Years-31.33%
Last Year-4.07%
Peers Comparison
Key metrics vs top competitors for Ridgetech Inc. (RDGT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.33 | $346 | — | -22.37% | 8.5% | 46.41% | — | |
| $807.33 | $97.04B | 21.04 | 12.36% | 1.18% | — | — | |
| $304.48 | $59.24B | 38.25 | 9.31% | 0.78% | 105.78% | — | |
| $239.71 | $56.41B | 37.16 | -1.87% | 0.62% | — | — | |
| $50.42 | $2.39B | 12.90 | -4.31% | 17.48% | 10.29% | — | |
| $2.98 | $7.49M | -0.04 | 28.73% | -545.72% | — | — |
Compare RDGT vs Peers
Ridgetech Inc. (RDGT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when RDGT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RDGT Frequently Asked Questions
Ridgetech Inc. (RDGT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Ridgetech Inc.'s revenue?
Ridgetech Inc. (RDGT) reported $258.7M in revenue for fiscal year 2025.
How fast is Ridgetech Inc. growing?
Ridgetech Inc. (RDGT) saw revenue decline by 22.4% over the past year.
Is RDGT profitable?
Yes, Ridgetech Inc. (RDGT) is profitable, generating $6.8M in net income for fiscal year 2025 (8.5% net margin).
Dividend & Returns
What is RDGT's return on equity?
Ridgetech Inc. (RDGT) has a return on equity (ROE) of 46.4%. This is excellent, indicating efficient use of shareholder capital.
What is Ridgetech Inc.'s free cash flow?
Ridgetech Inc. (RDGT) had negative free cash flow of $9.6M in fiscal year 2025, likely due to heavy capital investments.